Dechra hit by slowdown in pandemic pets boom
thetimes.co.uk
news
2022-10-20 23:01:00

Trading at one of Britain's biggest veterinary drugs companies has weakened, offering the latest sign of a waning of the pandemic-driven pets market boom.In an update before its annual shareholder meeting yesterday, Dechra Pharmaceuticals said trading in its first quarter was below the same period last year. However, it remained confident of hitting City forecasts of an underlying profit of Â£191 million.Dechra rode a wave during the Covid outbreak, benefiting from an increase in pet ownership and spending as people spent more time at home.
